Fecal Filtrate as a Treatment Option of Multiple Recurrent Clostridioides Difficile Infection (FILTRATE)
Fecal Filtrate Versus Conventional Microbiota Transplantation in the Treatment of Multiple Recurrent Clostridioides Difficile Infection (FILTRATE): A Protocol of a Randomized, Controlled Trial
Sponsor: University of Pecs
A PHASE3 clinical study on Clostridium Difficile Infection and Recurrent Clostridium Difficile Infection, this trial is ongoing. The trial is conducted by University of Pecs and has accumulated 6 data snapshots since 2023. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
6 versions recorded-
Jan 2026 — Present [monthly]
Unknown PHASE3
Status: Not Yet Recruiting → Unknown
-
Sep 2024 — Jan 2026 [monthly]
Not Yet Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting PHASE3
-
Jun 2023 — Jul 2024 [monthly]
Not Yet Recruiting PHASE3
-
Sep 2022 — Jun 2023 [monthly]
Not Yet Recruiting PHASE3
▶ Show 1 earlier version
-
Sep 2021 — Sep 2022 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Pecs
For direct contact, visit the study record on ClinicalTrials.gov .